Position in TAK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$578,990
New position
Shares Held
31,263
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Summit Trail Advisors, LLC holds $21,379,825 across 11 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
581,157 | $12,064,819 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
109,719 | $2,625,575 | |
| 3 | ZTS |
Zoetis Inc.
|
17,611 | $2,081,796 | |
| 4 | VTRS |
Viatris Inc
|
67,778 | $915,680 | |
| 5 | PRGO |
PERRIGO Co plc
|
72,968 | $783,676 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,298 | $769,688 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
31,263 | $578,990 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
3,835 | $505,222 |
All Filings in TAK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $578,990 | 31,263 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||